CRON vs. BHC, AUP, CARA, TEV, ABT, TLRY, NOT, PYR, SLS, and NVO
Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Bausch Health Companies (BHC), Aurinia Pharmaceuticals (AUP), Cara Operations (CARA), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Tilray Brands (TLRY), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Solaris Resources (SLS), and Novo Resources Corp. (NVO.V) (NVO). These companies are all part of the "pharmaceutical products" industry.
Cronos Group vs.
Bausch Health Companies (TSE:BHC) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, valuation, risk, dividends, earnings, analyst recommendations, institutional ownership, community ranking and media sentiment.
In the previous week, Bausch Health Companies' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score.
Bausch Health Companies has a beta of 0.77, meaning that its share price is 23% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.02, meaning that its share price is 2% more volatile than the S&P 500.
79.0% of Bausch Health Companies shares are owned by institutional investors. Comparatively, 16.0% of Cronos Group shares are owned by institutional investors. 11.3% of Bausch Health Companies shares are owned by company insiders. Comparatively, 46.4% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Cronos Group has a consensus price target of C$3.54, indicating a potential upside of 38.28%. Given Cronos Group's higher possible upside, analysts clearly believe Cronos Group is more favorable than Bausch Health Companies.
Cronos Group has lower revenue, but higher earnings than Bausch Health Companies. Cronos Group is trading at a lower price-to-earnings ratio than Bausch Health Companies, indicating that it is currently the more affordable of the two stocks.
Cronos Group received 30 more outperform votes than Bausch Health Companies when rated by MarketBeat users. However, 63.93% of users gave Bausch Health Companies an outperform vote while only 50.74% of users gave Cronos Group an outperform vote.
Bausch Health Companies has a net margin of -1.88% compared to Cronos Group's net margin of -42.65%. Bausch Health Companies' return on equity of 15.87% beat Cronos Group's return on equity.
Summary
Bausch Health Companies beats Cronos Group on 8 of the 15 factors compared between the two stocks.
Get Cronos Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cronos Group Competitors List
Related Companies and Tools
This page (TSE:CRON) was last updated on 3/29/2025 by MarketBeat.com Staff
